Less Ads, More Data, More Tools Register for FREE

Director Dealing

26 Apr 2013 12:21

RNS Number : 3522D
Advanced Oncotherapy PLC
26 April 2013
 



26 April 2013

 

ADVANCED ONCOTHERAPY Plc

("Advanced Oncotherapy" or "the Company")

 

Director Dealing

 

Advanced Oncotherapy (AIM: AVO) announces that on 25 April 2013, Tim Lebus, Non-Executive Director, purchased two tranches of ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares"), the first tranche of 750,000 Ordinary Shares at a price of 1.56 pence per Ordinary Share. The second tranche of 213,000 Ordinary Shares was purchased at a price of 1.545 pence per Ordinary Share.

 

Following this purchase, Tim Lebus now holds 963,000 Ordinary Shares, representing approximately 0.37 per cent. of the issued share capital of Advanced Oncotherapy.

 

For further information, please visit www.advancedoncotherapy.comor contact:

 

Michael Sinclair,

Chief Executive

Sandy Jamieson

Jon Levinson

Simon Hudson

Advanced

Oncotherapy Plc

Libertas Capital

Corporate Finance Ltd

Peterhouse

Corporate Finance

Tavistock Communications

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR & IR)

+44 20 3617 8739

+44 20 7569 9650

+44 20 7469 0930

+44 20 7920 3150

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBBGDSGDDBGXL

Related Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Back to RNS